Advanced Solid Tumors With KRAS G12C Mutations
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors With KRAS G12C Mutations
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors (NCT06244771) | Frontier Medicines Corporation | 2024-02-12 |
Track Advanced Solid Tumors With KRAS G12C Mutations automatically
Every clearance here is in the API, with alerts when new ones post.